NCT05180071 is a NA clinical trial of TEMA elbow system in Total Elbow Arthroplasty, sponsored by Limacorporate S.p.a.

Who is sponsoring NCT05180071?

NCT05180071 is sponsored by Limacorporate S.p.a.

What drugs are being tested in NCT05180071?

Interventions in NCT05180071: TEMA elbow system.

What condition does NCT05180071 study?

NCT05180071 studies Total Elbow Arthroplasty.

Is NCT05180071 still recruiting?

NCT05180071 is currently not yet recruiting. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT05180071

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA

Not yet recruiting NA Last updated 12 December 2023

What this trial tests

NA trial testing TEMA elbow system in Total Elbow Arthroplasty in 59 participants. Not yet recruiting.

Timeline

1 February 2024

Primary endpoint
30 June 2029

30 June 2029

Quick facts

Lead sponsor	Limacorporate S.p.a
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	59
Start date	1 February 2024
Primary completion	30 June 2029
Estimated completion	30 June 2029

Drugs / interventions tested

TEMA elbow system

Conditions studied

Total Elbow Arthroplasty — all drugs for Total Elbow Arthroplasty →

Sponsor

Limacorporate S.p.a

Who can join

18 and older, any sex, with Total Elbow Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TEMA elbow system is a CE marked medical device, and within this clinical trial it is used according to its intended use. This is a Post Marketing Clinical Follow Up trial, with the main aim to collect evidences on the outcome data on this product, by analysing clinical scoring systems, radiographs and adverse event records within five years after the surgery, and thus to assess the short-term performance and safety of this implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Limacorporate S.p.a trials

Trials by the same sponsor.

NCT05606120 — H-35 CL TRAUMA Cemented Femoral Stem · completed
NCT05007067 — H-29 DELTA Multihole TT Study. · terminated
NCT06870123 — Randomized MINIMA Stem with DELTA TT or DELTA ST-C · NA · active not recruiting
NCT04884542 — Multigen Plus H Study and AMF TT Cones · recruiting
NCT04594447 — Physica System KR Vs Physica System CR (K-20) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05180071 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Limacorporate S.p.a
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05180071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing